Significance of bulky mass and residual tumor—Treated with or without consolidative radiotherapy—To the risk of relapse in DLBCL patients-Reference-Cited by-同舟云学术

Significance of bulky mass and residual tumor—Treated with or without consolidative radiotherapy—To the risk of relapse in DLBCL patients

Published:2020-01-22 Issue:6 Volume:9 Page:1966-1977
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Med

Author:

Tokola Susanna¹^ORCID,Kuitunen Hanne¹,Turpeenniemi‐Hujanen Taina¹,Kuittinen Outi²

Affiliation:

1. Department of Oncology and Radiotherapy Oulu University Hospital Oulu University Oulu Finland

2. Faculty of Health Medicine Department of Oncology Institute of Clinical Medicine Kuopio University Hospital University of Eastern Finland Oulu Finland

Publisher

Wiley

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.2798

Reference25 articles.

1. 2016 US lymphoid malignancy statistics by World Health Organization subtypes

2. Incidence of hematologic malignancies in Europe by morphologic subtype: results of the HAEMACARE project

3. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012

4. Survival for haematological malignancies in Europe between 1997 and 2008 by region and age: results of EUROCARE-5, a population-based study

5. CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by the MabThera International Trial (MInT) Group

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development and validation of a novel prognostic nomogram for advanced diffuse large B cell lymphoma;Clinical and Experimental Medicine;2024-03-30

2. Definition of bulky disease in early stage diffuse large B-cell lymphoma in computed tomography on coronal and transverse planes;Frontiers in Oncology;2023-11-28

3. Development and Validation of a Novel Prognostic Nomogram for advanced Diffuse Large B-Cell Lymphoma;2023-10-28

4. Development and validation of a novel risk stratification model and a survival rate calculator for diffuse large B-cell lymphoma in the rituximab era: a multi-institutional cohort study;Annals of Hematology;2023-10-20

5. The expression of hypoxia inducible factor-1 alpha in diffuse large B-cell lymphoma (DLBCL) patients: a cross-sectional study in Indonesia;Annals of Medicine & Surgery;2023-08-15